Publicacións en colaboración con investigadores/as de Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (8)

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

2018

  1. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial

    Vaccine, Vol. 36, Núm. 38, pp. 5781-5788

2013

  1. Do socioeconomic inequalities in mortality vary between different Spanish cities? A pooled cross-sectional analysis

    BMC Public Health, Vol. 13, Núm. 1

  2. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Vaccine, Vol. 31, Núm. 46, pp. 5486-5494

  3. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

    Vaccine, Vol. 31, Núm. 42, pp. 4765-4774

  4. Mortality due to haematological cancer in cities close to petroleum refineries in Spain

    Environmental Science and Pollution Research, Vol. 20, Núm. 1, pp. 591-596

2012

  1. Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. 1166-1172

2011

  1. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain

    HUMAN VACCINES